Brief: Ryvu Therapeutics Signs Grant Deal With Medical Research Agency
23/04/2025 14:00
April 23 (Reuters) - Ryvu Therapeutics SA RVU.WA: SIGNS GRANT DEAL WITH MEDICAL RESEARCH AGENCY PROJECT AIMS TO DEVELOP NEW GENERATION PAYLOADS FOR ADC IN ONCOLOGY TOTAL NET VALUE OF PROJECT IS PLN 13.2 MILLION RECOMMENDED GRANT VALUE IS PLN 9.9 MILLION Source text: ID:nEM2nqHkra Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project